TTY BIOPHARM COMPANY LIMITED

Communiqués TTY Biopharm Company Limited

Actions

4105

TW0004105002

Cours en clôture Taipei Exchange Autres places de cotation 00:00:00 26/06/2024			Varia. 5j.	Varia. 1 janv.
76,5 ^TWD	+0,26 %		+0,26 %	-4,85 %

30/05	TTY Biopharm Company Limited annonce le changement des membres du comité d'audit	CI
30/05	TTY Biopharm Company Limited annonce le changement des membres du comité de développement durable	CI

Communiqués

Débloquez toutes les actualités : Soyez le premier informé et réagissez avant les marchés !

Inscription 100% Gratuite

DelveInsight Estimates a Diverse Kaposi Sarcoma Pipeline Comprising 5+ Companies Working in the Domain	03/03/23	AQ
TTY Biopharm : Announcement of TTY Biopharm's unaudited income information in July 2022	11/08/22	PU
TTY Biopharm : Announcement of the consolidated financial report for the second quarter of year 2022	05/08/22	PU
TTY Biopharm : To clarify report of China Times, Commercial Times and Economic Daily News on Aug 02, 2022	02/08/22	PU
TTY Biopharm : Announcement of TTY Biopharm's unaudited income information in June 2022	11/07/22	PU
TTY Biopharm : Announcement of the record date of cash dividend.	01/07/22	PU
TTY Biopharm : Announcement of TTY Biopharm's unaudited income information in May 2022	13/06/22	PU
TTY Biopharm : To announce the Company received milestone from global pharmaceutical company for co-development overseas market of long-lasting microsphere drug.	26/05/22	PU
TTY Biopharm : Important resolutions of the Company's 2022 Annual General Meeting	26/05/22	PU
TTY Biopharm : Announcement of TTY Biopharm's unaudited income information in Mar 2022	13/04/22	PU
TTY Biopharm : Announcement of TTY Biopharm's committee member of Remuneration committee resignation	31/03/22	PU
TTY Biopharm : The Company was invited by Fubon Securities to participate the on-line investors' conference.	25/03/22	PU
TTY Biopharm : Announcement of TTY Biopharm's unaudited income information in Feb 2022	11/03/22	PU
TTY Biopharm : Announcement of Year 2022 Annual General Meeting	09/03/22	PU
TTY Biopharm : To announce the change of General Manager	09/03/22	PU
TTY Biopharm : Announcement of the financial report for the year of 2021	09/03/22	PU
TTY Biopharm : Board of Directors proposed dividend distribution	09/03/22	PU
TTY : Biopharm Co Ltd. - TS-1 Capsule received TW NHI approval for Treatment of Patients with Locally Advanced or Metastatic Non-small Cell Lung Cancer	03/02/20	AQ

Aucun résultat pour cette recherche

Toute l'actualité Reco analystes Faits marquants Insiders Transcripts Communiqués Publications officielles Autres langues Idées de trading Articles Zonebourse Analyses Zonebourse

Filtres

Sécurisez et Augmentez la Performance de vos Investissements grâce à notre Équipe d'Experts à vos Côtés

Sécuriser mes Investissements

fermer